These products are 3rd-tier bait












More than any other classes of drugs, HMG-CoA reductase inhibitors and proton-pump inhibitors are affected by three-tier formularies. Nearly 4 in 5 HMOs that use a three-tier system will put one or more HMG-CoA reductase inhibitors for treatment of hypercholesterolemia on the third copayment tier, while more than 9 in 10 pharmacy benefit managers will do the same with at least one PPI. Pharmacy executives surveyed by the consultant Scott-Levin say high utilization and the availability of therapeutic equivalents invite use of the third tier for the three most-often-named classes. Products used to treat chronic conditions also commonly earn consideration for the highest tier.

Products routinely considered for third tier

SOURCE: BENEFIT DESIGN: HOW IT'S CHANGING MANAGED CARE, SCOTT-LEVIN, NEWTOWN, PA, JUNE 2001

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.